An analytical report on the global Pharmacovigilance And Drug Safety Software Market was released by Market Data Library, a reputable market research firm, and it predicts a significant growth trajectory during the forecast period. The market is anticipated to grow at a strong compound annual growth rate (CAGR) of 7.3% from 2021 to 2031, reaching a valuation of $432.3 million.

Chronic disease prevalence is on the rise due to the ageing population around the world, which has emerged as a major driver of market growth. Furthermore, the use of reliable pharmacovigilance and drug safety software solutions has become necessary as a result of the development of new drug pipelines and an increase in the frequency of adverse drug reactions (ADR). The demand for cutting-edge software in the pharmacovigilance arena has been further spurred by the strict regulatory criteria for medication safety set by regulatory agencies.

Get Full PDF Sample Copy of Report: https://marketdatalibrary.com/download-sample/4146

Another significant factor boosting market growth is the rising use of artificial intelligence (AI) and cloud technologies in pharmacovigilance software and solutions, according to the report. These innovative tools improve drug safety and compliance by enabling effective data analysis, on-the-spot monitoring of adverse events, and faster reporting procedures.

This in-depth market research report provides key industry players with insightful analyses of the current market dynamics, trends, and attractive growth possibilities. It provides businesses with the information necessary to make knowledgeable choices in the quickly developing global pharmacovigilance and drug safety software market.

Highlighted with 82 tables and 92 figures, this 173-page report “Global Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global pharmacovigilance and drug safety software market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global pharmacovigilance and drug safety software market in every aspect of the classification from perspectives of Functionality, Clinical Phase, Method, Delivery Mode, Indication, End User, and Region.

View Report Scope and Latest Developments in the Market: MW Link: -https://www.marketwatch.com/press-release/pharmacovigilance-and-drug-safety-software-market-is-expected-to-rise-at-a-high-cagr-of-73-by-2032-exclusive-report-by-market-data-library-2023-06-02?mod=search_headline

Based on Functionality, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Adverse Event Reporting Software
Drug Safety Audits Software
Issue Tracking Software
Fully Integrated Software

Based on Clinical Phase, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Pre-clinical
Phase I
Phase II
Phase III
Phase IV

By Method, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining

By Delivery Mode, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

On-premise Delivery
On-demand Delivery

By Indication, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Oncology
Respiratory Disorders
Cardiology
Neurology
Immunology
Pain Management
Other Indications

By End Users, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Business Process Outsourcing Firms (BPOs)
Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:

North America (U.S., Canada, and Mexico)
Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
South America (Brazil, Chile, Argentina, Rest of South America)
MEA (UAE，Saudi Arabia， South Africa and Rest of MEA)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Functionality, Delivery Mode and End User over the forecast years are also included.

Ask for Sample of Pharmacovigilance and Drug Safety Software Market Report

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Ab Cube

Accenture PLC

ArisGlobal LLC

Cognizant Technology Solutions Corporation

Ennov Solutions Inc.

Extedo GmbH

Honeywell International Inc. (Sparta Systems Inc.)

IQVIA Inc.

Max Application

Oracle Corporation

Sarjen Systems Pvt. Ltd.

United BioSource LLC

Veeva Systems Inc.

Wipro Limited

Get The Insights You Need By Customizing Your Report To Fit Your Unique Needs And Goals: https://marketdatalibrary.com/free-customization/4146

About Market Data Library:

Market Data Library is committed to providing clients with high-quality market research that is tailored to their specific needs. The Market Data Library provides corporate intelligence studies that ensure reliable and accurate research data across a diverse range of industries, including Health Care, Chemicals, Packaging, ICT, Automotive, Industrial Automation, Agriculture, and Finance. Our team is comprised of various departments, including sales, operations, finance, research, and analytics, as well as the scientist and data scientist teams. Our business offerings portray the most up-to-date, rational information a company needs to compete effectively. To guarantee that our clients have access to information and insights whenever they need them, we provide 24/7 research support.

Contact Us

Market Data Library

Tel: +1-(718)-312-8686

Email: [email protected]

Website: marketdatalibrary.com/

LinkedIn | Facebook | Twitter